Literature DB >> 8816884

Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response.

W J van Driel1, P C Hogendoorn, F W Jansen, A H Zwinderman, J B Trimbos, G J Fleuren.   

Abstract

The local inflammatory tumor infiltrate related to cervical carcinoma has been shown to consist mainly of T lymphocytes and macrophages. In 5% to 40% of the cases, eosinophilic granulocytes from a major part of the tumor-infiltrating cells. The presence of a high percentage of eosinophilic granulocytes in the infiltrate might reflect a less effective antitumor response, resulting in a worse overall survival. In the present study, histological slides from 83 patients who had been treated for cervical squamous carcinoma were reviewed. Special emphasis was put on the presence of eosinophils in the tumor infiltrate and correlated with clinical outcome as a parameter of the strength of the host-antitumor response. Multivariate analysis showed that the presence of a large amount of eosinophils among the infiltrate was an independent parameter, predicting a worse overall survival in patients with tumor-negative lymph nodes and tumor-negative resection margins (n = 61). The presence of eosinophilic granulocytes might represent a less appropriate immune response based on a disturbed equilibrium between Th-1- and Th-2-mediated immune response.

Entities:  

Mesh:

Year:  1996        PMID: 8816884     DOI: 10.1016/s0046-8177(96)90216-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  28 in total

Review 1.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

2.  Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation.

Authors:  S Ali; J Kaur; K D Patel
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 3.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

4.  Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth.

Authors:  Rachel A Cederberg; Sarah Elizabeth Franks; Brennan J Wadsworth; Alvina So; Lisa R Decotret; Michael G Hall; Rocky Shi; Michael R Hughes; Kelly M McNagny; Kevin L Bennewith
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

5.  Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.

Authors:  Simone Wendlinger; Jonas Wohlfarth; Sophia Kreft; Claudia Siedel; Teresa Kilian; Ulrich Dischinger; Markus V Heppt; Kilian Wistuba-Hamprecht; Friedegund Meier; Matthias Goebeler; Dirk Schadendorf; Anja Gesierich; Corinna Kosnopfel; Bastian Schilling
Journal:  Cancers (Basel)       Date:  2022-05-04       Impact factor: 6.575

6.  Tumour-Associated Tissue Eosinophilia in Oral Squamous Cell Carcinoma- A Boon or a Bane?

Authors:  Shweta Yellapurkar; Srikant Natarajan; Karen Boaz; Mohan Baliga; Premalatha Shetty; Nidhi Manaktala; Mukul Prasad; Mahalakshmi Ravi
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 7.  Myeloid Cells as Targets for Therapy in Solid Tumors.

Authors:  Tiziana Cotechini; Terry R Medler; Lisa M Coussens
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

8.  CCL24 Signaling in the Tumor Microenvironment.

Authors:  Sung-Jig Lim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

10.  Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma.

Authors:  Dae Woo Lee; Young Tae Kim; Sang Wun Kim; SungHoon Kim; Jae Hoon Kim; Myung Hwa Kang; Jeong Hye Hwang; Jong baeck Lim
Journal:  Clin Vaccine Immunol       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.